Alzheimer's: Men and women's brains affected differently, study finds

A new study led by researchers at Georgia State University reports that Alzheimer’s disease produces different patterns of brain atrophy in men and women, with implications for screening and clinical care. The findings were published in the journal Brain Communications and highlight limits of one-size-fits-all cognitive testing.

The team examined brain scans and clinical data from 332 individuals across diagnostic stages and found sex-dependent trajectories: men tended to show greater gray-matter loss earlier, from cognitively healthy status to mild cognitive impairment (MCI), while women exhibited a steeper and more widespread decline from MCI to Alzheimer’s. Senior author Mukesh Dhamala noted that standard tools such as the 30-point Mini-Mental State Examination (MMSE) may not fully reflect underlying structural changes in women.

Clinically, the results suggest that relying solely on score-based screening could under-detect disease progression in some female patients and that imaging or biomarker assessments might need greater weight in sex-specific diagnostic pathways. The authors argue this could justify reconsidering diagnostic thresholds and follow-up intervals to better capture disease state across sexes.

In the broader research context, the study adds to evidence that biological factors — including hormonal influences and APOE genotype interactions — and compensatory brain network recruitment may drive observed sex differences. The investigators emphasize the need for longitudinal work to determine mechanisms and to assess whether sex-calibrated clinical protocols improve early detection and outcomes.

Commentators caution that while the study is influential, it does not yet mandate immediate changes to standard practice; rather it frames priorities for future trials and guideline committees. Analysts expect follow-up studies and consensus statements from clinical bodies to guide whether and how screening tools and care pathways should be adapted to account for sex-specific disease trajectories.